NASDAQ:AMED • US0234361089
The current stock price of AMED is 100.99 USD. Today AMED is up by 0.01%. In the past month the price increased by 3.61%. In the past year, price increased by 2.68%.
ChartMill assigns a technical rating of 8 / 10 to AMED. When comparing the yearly performance of all stocks, AMED turns out to be only a medium performer in the overall market: it outperformed 48.13% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to AMED. AMED scores excellent on profitability, but there are some minor concerns on its financial health.
On July 29, 2025 AMED reported an EPS of 1.54 and a revenue of 621.86M. The company beat EPS expectations (13.43% surprise) and beat revenue expectations (0.01% surprise).
17 analysts have analysed AMED and the average price target is 102.87 USD. This implies a price increase of 1.87% is expected in the next year compared to the current price of 100.99.
For the next year, analysts expect an EPS growth of 13.17% and a revenue growth 4.17% for AMED
Over the last trailing twelve months AMED reported a non-GAAP Earnings per Share(EPS) of 4.75. The EPS increased by 11.24% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 3.56% | ||
| ROA | 3.87% | ||
| ROE | 6.95% | ||
| Debt/Equity | 0.26 |
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 10.74 | 99.131B | ||
| CI | THE CIGNA GROUP | 8.69 | 71.564B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 99.07 | 26.592B | ||
| LH | LABCORP HOLDINGS INC | 14.97 | 22.356B | ||
| DGX | QUEST DIAGNOSTICS INC | 18.55 | 21.887B | ||
| GH | GUARDANT HEALTH INC | N/A | 11.75B | ||
| DVA | DAVITA INC | 10.66 | 10.071B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 29.92 | 8.03B | ||
| CHE | CHEMED CORP | 16.82 | 5.617B | ||
| RDNT | RADNET INC | 76.27 | 4.696B | ||
| OPCH | OPTION CARE HEALTH INC | 15.64 | 4.668B | ||
| HNGE | HINGE HEALTH INC-A | 23.9 | 3.632B | ||
| HIMS | HIMS & HERS HEALTH INC | 28.82 | 3.588B |
View all stocks in the Health Care Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Amedisys, Inc. engages in the provision of healthcare services. The company is headquartered in Baton Rouge, Louisiana and currently employs 19,000 full-time employees. The company provides in-home healthcare and related services to the chronic, co-morbid and aging American population. Its segments include home health, hospice and high acuity care. Its home health segment delivers a range of services in the homes of individuals who may be recovering from an illness, injury or surgery. Its nurses administer medications, care for wounds, monitor vital signs and provide a range of other nursing services. Its hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. Its high acuity care segment delivers the essential elements of inpatient hospital, palliative and skilled nursing facility care to patients in their homes. The company owns and operates 347 Medicare-certified home health care centers, 164 Medicare-certified hospice care centers and eight admitting high acuity care joint ventures in 38 states within the United States and the District of Columbia.
AMEDISYS INC
3854 American Way, Suite A
Baton Rouge LOUISIANA 70816 US
CEO: Paul B. Kusserow
Employees: 19000
Phone: 12252922031
Amedisys, Inc. engages in the provision of healthcare services. The company is headquartered in Baton Rouge, Louisiana and currently employs 19,000 full-time employees. The company provides in-home healthcare and related services to the chronic, co-morbid and aging American population. Its segments include home health, hospice and high acuity care. Its home health segment delivers a range of services in the homes of individuals who may be recovering from an illness, injury or surgery. Its nurses administer medications, care for wounds, monitor vital signs and provide a range of other nursing services. Its hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. Its high acuity care segment delivers the essential elements of inpatient hospital, palliative and skilled nursing facility care to patients in their homes. The company owns and operates 347 Medicare-certified home health care centers, 164 Medicare-certified hospice care centers and eight admitting high acuity care joint ventures in 38 states within the United States and the District of Columbia.
The current stock price of AMED is 100.99 USD. The price increased by 0.01% in the last trading session.
AMED does not pay a dividend.
AMED has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
AMEDISYS INC (AMED) operates in the Health Care sector and the Health Care Providers & Services industry.
AMEDISYS INC (AMED) currently has 19000 employees.
AMEDISYS INC (AMED) has a market capitalization of 3.32B USD. This makes AMED a Mid Cap stock.